Prodynorphin gene expression relates to NF-kappa B factors

Area of Science:

• Molecular Biology
• Neuroscience
• Oncology

Background:

• The prodynorphin gene has kappa B motifs, suggesting regulation by kappa B-specific DNA-binding factors.
• Prodynorphin is expressed in human tumor cell lines, where NF-kappa B/c-Rel family factors are also present.

Purpose of the Study:

• To identify and characterize kappa B-specific DNA-binding factors in human tumor cell lines.
• To investigate the correlation between these factors and prodynorphin/proenkephalin mRNA levels.
• To determine if these factors bind to regulatory sequences within the dynorphin A gene.

Main Methods:

• Electromobility shift assay (EMSA)
• Immunoabsorption assays
• UV cross-linking experiments
• mRNA level analysis

Main Results:

• Three main kappa B-specific factors (p50 homodimer, NF-kappa B, p65/c-Rel heterodimer) and novel minor factors (including p125) were identified.
• Prodynorphin mRNA levels negatively correlated with p50 homodimer and positively with the p65/c-Rel to NF-kappa B ratio.
• The p50 homodimer specifically bound to a kappa B-like motif in the dynorphin A gene, suppressing transcription.

Conclusions:

• NF-kappa B/c-Rel family factors, particularly the p50 homodimer, play a significant role in regulating prodynorphin gene expression in tumor cells.
• The p50 homodimer acts as a transcriptional repressor by binding to an intragenic motif within the dynorphin A gene sequence.